{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:27:06Z","timestamp":1762079226912},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ncl.2010.03.002","type":"journal-article","created":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T05:20:50Z","timestamp":1274160050000},"page":"581-591","source":"Crossref","is-referenced-by-count":10,"title":["Giant Cell Arteritis"],"prefix":"10.1016","volume":"28","author":[{"given":"Julie","family":"Falardeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2010.03.002_bib1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/art.1780261007","article-title":"The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee","volume":"26","author":"Smith Carolyn","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ncl.2010.03.002_bib2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0161-6420(01)00574-7","article-title":"The epidemiology of giant cell arteritis","volume":"108","author":"Liu","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.002_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/art.1780310607","article-title":"Trends in incidence and clinical presentation of temporal arteritis in Olmstead County, Minnesota, 1950\u20131985","volume":"31","author":"Machado","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"10.1016\/j.ncl.2010.03.002_bib4","first-page":"79","article-title":"Epidemiology of giant cell arteritis","volume":"69","author":"Hunder","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.ncl.2010.03.002_bib5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/art.1780370705","article-title":"Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis","volume":"37","author":"Baldursson","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ncl.2010.03.002_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0002-9394(14)70123-0","article-title":"Giant cell arteritis: validity and reliability of various diagnostic criteria","volume":"123","author":"Hayreh","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.002_bib7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1365-2230.2003.01323.x","article-title":"Scalp necrosis in temporal arteritis","volume":"28","author":"Campbell","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ncl.2010.03.002_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0161-6420(86)33706-0","article-title":"Temporal arteritis. A clinicopathologic study","volume":"93","author":"McDonnell","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.002_bib9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1212\/WNL.38.3.352","article-title":"Neurologic disease in biopsy-proven giant cell (temporal) arteritis","volume":"38","author":"Caselli","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2010.03.002_bib10","first-page":"751","article-title":"The involvement of the peripheral nervous system in biopsy-proven active giant cell arteritis","volume":"254","author":"Pfadenhauer","year":"2007","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2010.03.002_bib11","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","article-title":"Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment","volume":"41","author":"Gonzales-Gay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ncl.2010.03.002_bib12","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/art.22359","article-title":"Giant cell arteritis: involvement of intracranial arteries","volume":"55","author":"Salvarani","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ncl.2010.03.002_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F","article-title":"Disease pattern in cranial and large-vessel giant cell arteritis","volume":"42","author":"Brack","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ncl.2010.03.002_bib14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.7326\/0003-4819-83-6-806","article-title":"Large artery involvement in giant cell (temporal) arteritis","volume":"83","author":"Klein","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ncl.2010.03.002_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00002281-200201000-00002","article-title":"Giant cell arteritis","volume":"14","author":"Levine","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ncl.2010.03.002_bib16","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.11353","article-title":"Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and\/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years","volume":"48","author":"Nuenninghoff","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ncl.2010.03.002_bib17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/ard.2005.046912","article-title":"Incidence of diagnosed polymyalgia rheumatica and giant cell arteritis in the United Kingdom, 1990\u20132001","volume":"65","author":"Smeeth","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ncl.2010.03.002_bib18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"372","author":"Salvarani","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2010.03.002_bib19","first-page":"S130","article-title":"Management guidelines and outcome measures in polymyalgia rheumatica (PMR)","volume":"25","author":"Dasgupta","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ncl.2010.03.002_bib20","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.4065\/81.8.1071","article-title":"The early history of giant cell arteritis and polymyalgia rheumatica: first descriptions to 1970","volume":"81","author":"Hunder","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ncl.2010.03.002_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"347","author":"Salvarani","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2010.03.002_bib22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11606-006-0024-0","article-title":"Giant cell arteritis presenting as small bowel infarction","volume":"22","author":"Annamalai","year":"2007","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.ncl.2010.03.002_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/MD.0b013e3181646118","article-title":"Mesenteric involvement in giant cell arteritis. An under-recognized complication? Analysis of a case series with clinicoanatomic correlation","volume":"87","author":"Scola","year":"2008","journal-title":"Medicine"},{"key":"10.1016\/j.ncl.2010.03.002_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00005792-200301000-00002","article-title":"Audiovestibular manifestations in giant cell arteritis: a prospective study","volume":"82","author":"Amor-Dorado","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.ncl.2010.03.002_bib25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","article-title":"Ocular manifestations of giant cell arteritis","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ncl.2010.03.002_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis: trends and clinical spectrum in 161 patients","volume":"79","author":"Gonzales-Gay","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.ncl.2010.03.002_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000070631","article-title":"Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies","volume":"217","author":"Hayreh","year":"2003","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ncl.2010.03.002_bib28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/112067219700700412","article-title":"Neuro-ophthalmic complications of biopsy-proven giant cell arteritis","volume":"7","author":"Glutz Von Blotzheim","year":"1997","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.002_bib29","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0889-857X(05)70235-0","article-title":"Visual manifestations of temporal arteritis","volume":"27","author":"Miller","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.ncl.2010.03.002_bib30","first-page":"349","article-title":"Ischemic optic neuropathy","volume":"vol. 1","author":"Arnold","year":"2005"},{"key":"10.1016\/j.ncl.2010.03.002_bib31","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ophtha.2005.01.036","article-title":"Poor prognosis of visual outcome after visual loss from giant cell arteritis","volume":"112","author":"Danesh-Meyer","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.002_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1755-3768.2008.01314.x","article-title":"Giant cell arteritis: an updated review","volume":"87","author":"Kawasaki","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.002_bib33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s004170100310","article-title":"Orbital presentations of giant cell arteritis","volume":"239","author":"Lee","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.002_bib34","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0161-6420(94)31102-X","article-title":"Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision","volume":"101","author":"Liu","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.002_bib35","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ncl.2010.03.002_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.286.6361.266","article-title":"Simple rule for calculating normal erythrocyte sedimentation rate","volume":"286","author":"Miller","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.ncl.2010.03.002_bib37","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.ophtha.2006.05.020","article-title":"Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis","volume":"113","author":"Parikh","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.002_bib38","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0161-6420(02)01076-X","article-title":"Thrombocytosis in patients with biopsy-proven giant cell arteritis","volume":"109","author":"Foroozan","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.002_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/112067210401400310","article-title":"Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy","volume":"14","author":"Costello","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.002_bib40","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ophtha.2005.01.031","article-title":"Management of the patient with suspected temporal arteritis","volume":"112","author":"Niederkohr","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.002_bib41","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7","article-title":"Treatment of giant cell arteritis: interleukine-6 as a biologic marker of disease activity","volume":"43","author":"Weyand","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ncl.2010.03.002_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11936-006-0007-9","article-title":"Current diagnosis and treatment of temporal arteritis","volume":"8","author":"Schmidt","year":"2006","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.ncl.2010.03.002_bib43","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.ophtha.2009.02.027","article-title":"Clinicopathologic correlations in giant cell arteritis","volume":"116","author":"Zhou","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.002_bib44","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199711063371902","article-title":"Color duplex ultrasonography useful for the diagnosis of temporal arteritis","volume":"337","author":"Schmidt","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2010.03.002_bib45","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1186\/ar2003","article-title":"Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis","volume":"8","author":"Karahaliou","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ncl.2010.03.002_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/BOR.0b013e32831cec7b","article-title":"Imaging for large-vessel vasculitis","volume":"21","author":"Blockmans","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ncl.2010.03.002_bib47","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3174\/ajnr.A0638","article-title":"Diagnostic value of high-resolution MR imaging in giant cell arteritis","volume":"28","author":"Bley","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ncl.2010.03.002_bib48","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/rheumatology\/kep011","article-title":"Involvement of the ophthalmic artery in giant cell arteritis visualized by 3T MRI","volume":"48","author":"Geiger","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.ncl.2010.03.002_bib49","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/rheumatology\/keh513","article-title":"Giant cell arteritis and polymyalgia rheumatic: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis","volume":"44","author":"Narvaez","year":"2005","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.ncl.2010.03.002_bib50","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/NRL.0b013e3181836add","article-title":"The clinical utility of high-resolution magnetic resonance imaging in the diagnosis of giant cell arteritis","volume":"14","author":"Khoury","year":"2008","journal-title":"Neurologist"},{"key":"10.1016\/j.ncl.2010.03.002_bib51","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/ICU.0b013e328310da01","article-title":"Giant cell arteritis","volume":"19","author":"Hall","year":"2008","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.002_bib52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/art.21699","article-title":"Repetitive 18F-fluorodeoxyglucose position emission tomography in giant cell arteritis: a prospective study of 35 patients","volume":"55","author":"Blockmans","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ncl.2010.03.002_bib53","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00003072-200008000-00018","article-title":"Imaging of giant cell arteritis: evidence of splenic involvement using FDG positron emission tomography","volume":"25","author":"De Winter","year":"2000","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.ncl.2010.03.002_bib54","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jvs.2008.04.054","article-title":"Giant cell arteritis: heterogeneity in clinical presentation and imaging results","volume":"48","author":"Janssen","year":"2008","journal-title":"J\u00a0Vasc Surg"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.002_bib55","first-page":"140","article-title":"The treatment of giant cell arteritis","volume":"5","author":"Fraser","year":"2008","journal-title":"Rev Neurol Dis"},{"key":"10.1016\/j.ncl.2010.03.002_bib56","first-page":"1484","article-title":"A\u00a0randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment if simple forms of giant cell arteritis: a one year follow-up study of 164 patients","volume":"27","author":"Chevalet","year":"2000","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ncl.2010.03.002_bib57","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1002\/art.22163","article-title":"Treatment of giant cell arteritis using induction therapy with high-dose corticosteroids: a double-blind, placebo-controlled, randomized prospective clinical trial","volume":"54","author":"Mazlumzadeh","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ncl.2010.03.002_bib58","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/bjo.85.9.1061","article-title":"Steroid management in giant cell arteritis","volume":"85","author":"Chan","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.002_bib59","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1034\/j.1600-0420.2002.800403.x","article-title":"Visual improvement with corticosteroid therapy in giant cell arteritis: report of a large study and review of the literature","volume":"80","author":"Hayreh","year":"2002","journal-title":"Acta Ophthalmol Scand"},{"issue":"5","key":"10.1016\/j.ncl.2010.03.002_bib60","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ncl.2010.03.002_bib61","first-page":"495","article-title":"A\u00a0prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis","volume":"19","author":"Spiera","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ncl.2010.03.002_bib62","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.10262","article-title":"A\u00a0multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis","volume":"46","author":"Hoffman","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ncl.2010.03.002_bib63","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","article-title":"Combined treatment of giant cell arteritis with methotrexate and prednisone","volume":"134","author":"Jover","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ncl.2010.03.002_bib64","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","article-title":"Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis","volume":"56","author":"Marh","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.002_bib65","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.berh.2009.04.001","article-title":"Treatment and outcomes of large vessel arteritis","volume":"23","author":"Borg","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.ncl.2010.03.002_bib66","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1002\/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y","article-title":"Treatment of longstanding active giant cell arteritis with infliximab","volume":"44","author":"Cantini","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ncl.2010.03.002_bib67","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/ard.62.11.1116","article-title":"Experience of infliximab (anti-TNF\u03b1 monoclonal antibody) as monotherapy for giant cell arteritis","volume":"62","author":"Andonopoulos","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ncl.2010.03.002_bib68","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","article-title":"infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial","volume":"146","author":"Hoffman","year":"2007","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ncl.2010.03.002_bib69","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.2007.082115","article-title":"A\u00a0double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects","volume":"67","author":"Martinez-Taboada","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ncl.2010.03.002_bib70","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/ard.2005.036533","article-title":"Anti-CD20 monoclonal antibody (Rituximab) as an adjunct in the treatment of giant cell arteritis","volume":"64","author":"Bhatia","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ncl.2010.03.002_bib71","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low dose aspirin and prevention of cranial ischemic complications in giant cell arteritis","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.002_bib72","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/gerona\/gln030","article-title":"Giant cell arteritis and mortality","volume":"64","author":"Crow","year":"2009","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386191000040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386191000040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T07:40:19Z","timestamp":1559115619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386191000040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S073386191000040X"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2010.03.002","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}